Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: Relation with inflammation

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 955-963

  Koc, Mehmet ^a   Toprak, Ahmet ^b   Arikan, Hakki ^a   Odabasi, Zekaver ^a   Elbir, Yesim ^a   Tulunay, Aysin ^a   Asicioglu, Ebru ^a   Eksioglu Demiralp, Emel ^a   Glorieux, Griet ^c   Vanholder, Raymond ^c   Akoglu, Emel ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

chronic kidney disease; haemodialysis; inflammation; Toll like receptor

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 6; POLYSULFONE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FLUORESCENCE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY POLYCYSTIC DISEASE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE REGRESSION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNIVARIATE ANALYSIS;

CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MONOCYTES; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 79952182053     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq500     Document Type: Article

References (34)

1. Qureshi AR, Alvestrand A, Divino-Filho JC et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13: S28-S36
2. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002;15:329-337
3. Haeffner-Cavaillon N, Cavaillon JM, Ciancioni C et al. Invivo induction of interleukin-1 during hemodialysis. Kidney Int 1989;35:1212-1218
4. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001;107:13-19 (Pubitemid 32047406)
5. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511 (Pubitemid 38931765)
6. Janeway CA Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216 (Pubitemid 34293424)
7. Ando M, Shibuya A, Tsuchiya K et al. Reduced expression of Tolllike receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int 2006;70:358-362 (Pubitemid 44086586)
8. Kuroki Y, Tsuchida K, Go I et al. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and-4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med 2007;19:783-790
9. Barreto DV, Barreto FC, Liabeuf S et al. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and predialysis patients with chronic kidney disease. Kidney Int 2010;77:550-556
10. Glorieux G, Schepers E, Schindler R et al. A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test. Nephrol Dial Transplant 2009;24:548-554
11. Niessner A, Steiner S, Speidl WS et al. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 2006;189:408-413 (Pubitemid 44634488)
12. Wittebole X, Coyle SM, Kumar A et al. Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating. Clin Exp Immunol 2005;141:99-106 (Pubitemid 40904646)
13. Comin F, Speziali E, Martins-Filho OA et al. Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis. Clin Exp Immunol 2007;149:274-284 (Pubitemid 47063045)
14. Sester U, Sester M, Heine G et al. Strong depletion of CD14 (+) CD16 (+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 2001;16:1402-1408 (Pubitemid 32640595)
15. Musial K, Szprynger K, Szczepanska M et al. Heat shock proteins in children and young adults on chronic hemodialysis. Pediatr Nephrol 2009;24:2029-2034
16. Liu G, Zhao Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 2007;122:149-156 (Pubitemid 47389958)
17. Tsuchida K, Takemoto Y, Yamagami S et al. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods. Nephron 1997;75:438-443 (Pubitemid 27156738)
18. Bosisio D, Polentarutti N, Sironi M et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferongamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002;99:3427-3431 (Pubitemid 34525326)
19. Schouten WE, Grooteman MP, Schoorl M et al. Monocyte activation in peripheral blood and dialyser eluates: phenotypic profile and cytokine release. Nephron 2002;91:646-653 (Pubitemid 34914066)
20. Tamandl D, Bahrami M, Wessner B et al. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 2003;20:224-229
21. Iwahashi M, Yamamura M, Aita T et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004;50:1457-1467 (Pubitemid 38608067)
22. Haruta Y, Koarada S, Tada y et al. High expression of Toll-like receptor 4 on CD14+ monocytes in acute infectious diseases. Scand J Infect Dis 2007;39:577-583 (Pubitemid 47009168)
23. Yang ZX, Liang Y, Zhu y et al. Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis. Clin Exp Immunol 2007;149:48-55 (Pubitemid 46897106)
24. Glorieux G, Cohen G, Jankowski J et al. Platelet/leukocyte activation, inflammation, and uremia. Semin Dial 2009;22:423-427
25. Ji Y, Liu J, Wang Z et al. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 2009;23:265-276
26. Goncalves S, Pecoits-Filho R, Perreto S et al. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant 2006;21:2788-2794 (Pubitemid 44542232)
27. Laude-Sharp M, Caroff M, Simard L et al. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int 1990;38:1089-1094
28. Schindler R, Beck W, Deppisch R et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol 2004;15:3207-3214 (Pubitemid 39578853)
29. Pertosa G, Gesualdo L, Tarantino EA et al. Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. Kidney Int 1993;43: S149-S153
30. Linnenweber S, Lonnemann G. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells. Kidney Int Suppl 2001;78: S282-S285 (Pubitemid 32144114)
31. Hoffmann U, Fischereder M, Marx M et al. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material? Am J Nephrol 2003;23:442-447 (Pubitemid 37465108)
32. Horl WH. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 2002;13: S62-S71
33. Armstrong L, Medford AR, Hunter KJ et al. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 2004;136:312-319 (Pubitemid 38543451)
34. Skinner NA, MacIsaac CM, Hamilton JA et al. Regulation of Tolllike receptor (TLR) 2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin Exp Immunol 2005;141:270-278 (Pubitemid 41003351)